Match Document Document Title
US20110124588 SYNERGISTIC ACTIVE INGREDIENT COMBINATIONS  
The novel active compound combinations comprising compounds of the formulae (I) and (II) have very good insecticidal and acaricidal properties.
US20120122682 PESTICIDAL SUSPO-EMULSION COMPOSITIONS  
The present invention relates to formulation comprising at least (i) two pesticidal compounds A and B dissolved in a lactic acid ester and wherein a) both A and B have melting points below 900C b)...
US20130225644 MODIFIED LYSINE-MIMETIC COMPOUNDS  
Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.
US20100173859 PHARMACEUTICAL FORMULATION FOR THE PRODUCTION OF RAPIDLY DISINTERGRATING TABLETS  
Pharmaceutical formulation in the form of compacts comprising A) an agglomerated excipient content composed of a1) 60-97% by weight of sugar or sugar alcohols,a2) 1-25% by weight of a...
US20110159114 COMBINATION COMPRISING AN IRON CHELATOR AND AN ANTI-NEOPLASTIC AGENT AND USE THEREOF  
The present invention relates to a combination comprising a a substituted 3,5-diphenyl-1,2,4-triazole, e.g. 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic acid and at least one...
US20100197621 METHODS OF REDUCING THE PROLIFERATION AND VIABILITY OF MICROBIAL AGENTS  
The invention relates to formulations of an antimicrobial agent, a lipid, and optionally a surfactant, and uses thereof for reducing the proliferation and viability of microbial agents.
US20070224263 Aminoalkylphosphonates and related compounds as Edg receptor agonists  
The present invention encompasses compounds of Formula II: as well as the pharmaceutically acceptable salts and hydrates thereof. The compounds are useful for treating immune mediated diseases and...
US20100173897 SUBSTITUTED N-PHENYL-BIPYRROLIDINE CARBOXAMIDES AND THERAPEUTIC USE THEREOF  
The present invention discloses and claims a series of substituted N-phenyl-bipyrrolidine carboxamides of formula (I). Wherein R, R1, R2, R3 and R4 are as described herein. More specifically, the...
US20100311765 METABOLIC DEGRADATION INHIBITORS FOR ANTI-HYPERPROLIFERATIVE AGENTS  
The present invention provides methods of increasing an amount of a treatment agent in the body, a cancer or tumor. The methods include administering an inhibitor of the metabolic degradation or...
US20130197011 Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament  
Substituted phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones which are glycine transporter-1 (GlyT1) inhibitors. These are useful for the treatment of schizophrenia, Alzheimer's Disease and other...
US20120029032 MATRIX-TYPE SUSTAINED RELEASE PREPARATION CONTAINING BASIC ADDITIVE  
Disclosed is a matrix-type sustained release preparation containing a basic drug unstable against an acid as an active pharmaceutical ingredient, wherein the decomposition of the basic drug...
US20140243194 Fungicidal substituted 1--1H-[1,2,4]triazole compounds  
The present invention relates to substituted 1-{2-[2-halo-4-(4-halogen-phenoxy)-phenyl]-2-alkynyloxy-ethy l}-1H-[1,2,4]triazole compounds of formula I as defined in the description, and the...
US20140235441 Fungicidal Substituted 1--1H-[1,2,4]triazole Compounds  
The present invention relates to substituted 1-{2-cyclyloxy-2-[2-halo-4-(4-halogen-phenoxy)-phenyl]-ethyl }-1H-[1,2,4]triazole compounds of formula I as defined in the description, and the...
US20140206538 Fungicidal substituted 1--1H-[1,2,4]triazole compounds  
The present invention relates to substituted 1-{2-[2-halo-4-(4-halogen-phenoxy)-phenyl]-2-alkoxy-2-alkyny l-ethyl}-1H-[1,2,4]triazole compounds of formula I as defined in the description, and the...
US20140187422 Fungicidal substituted 1--1H-[1,2,4]triazole compounds  
The present invention relates to substituted 1-{2-[2-halo-4-(4-halogen-phenoxy)-phenyl]-2-alkoxy-2-cyclyl -ethyl}-1H-[1,2,4]triazole compounds of formula I as defined in the description, and the...
US20140162876 Fungicidal substituted 1--1H-[1,2,4]triazole compounds  
The present invention relates to substituted 1-{2-[2-halo-4-(4-halogen-phenoxy)phenyl]-2-ethoxy-ethyl}-1H -[1,2,4]triazole compounds of formula I as defined in the description, and the N-oxides,...
US20070054907 Novel modulators of the PPAR-type receptors and pharmaceutical/cosmetic applications thereof  
Novel compounds that are modulators of PPAR-type receptors having the structural formula (I): are formulated into pharmaceutical compositions suited for administration in human or veterinary...
US20100190762 TRIAZOLYL PHENYL BENZENESULFONAMIDES  
Compounds are provided that act as potent antagonists of the CCR2 or CCR9 receptor. Animal testing demonstrates that these compounds are useful for treating inflammation, a hallmark disease for...
US20050154030 Antimicrobial composition  
An antimicrobial composition comprising a microemulsion for imparting antimicrobial characteristics to numerous products. The microemulsion can be aqueous or non-aqueous. A method of making the...
US20090305893 Plant Growth regulating and Fungicidal Compositions  
The present invention provides a composition capable of regulating growth of a plant or propagation material thereof comprising as plant growth regulating active ingredient a mixture of component...
US20100120878 FORMULATION  
This invention relates to mixtures of triazole compounds and in particular to the use of such mixtures in non-crystallising compositions. It relates to mixtures that are concentrated solutions and...
US20110097413 SOLID STATE FORMS OF DEFERASIROX SALTS AND PROCESS FOR THE PREPARATION THEREOF  
Provided herein are novel solid state forms of deferasirox salts, process for the preparation, pharmaceutical compositions, and method of treating thereof. The solid state forms of deferasirox...
US20080312184 Composition for Preventing Plant Diseases and Method for Preventing the Diseases  
The present invention is to provide a composition for preventing plant diseases which comprises at least Component I and Component II, is capable of obtaining a synergic effect that cannot be...
US20100292187 METHODS FOR TREATING HEPATITIS C  
The present invention provides compounds, pharmaceutical compositions, and methods of using such compounds or compositions for treating infection by a virus, or for affecting viral IRES activity.
US20150165044 Hydrophilic Polyurethane Compositions  
This disclosure relates to a controlled-release composition containing a water-swellable linear polymer together with an active agent. The water-swellable linear polymer is obtained by reacting...
US20090215845 Fungicidal mixtures  
Synergistically effective mixtures comprising prochloraz and tebuconazole and fungicidal compositions based thereon are highly suitable for protecting industrial materials, in particular wood and...
US20140371222 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY  
The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of...
US20110319447 TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY  
The present invention relates to substituted triazole compounds and compositions comprising substituted triazole compounds. The invention further relates to methods of inhibiting the activity of...
US20140364408 Hydrazide Containing Nuclear Transport Modulators And Uses Thereof  
The invention generally relates to nuclear transport modulators, e.g., CRM1 inhibitors, and more particularly to a compound represented by structural formula (I): or a pharmaceutically acceptable...
US20070043011 Substituted benzanilide compound and noxious organism controlling agent  
The present invention is to provide a novel agrigultural chemical, particularly an insecticide or acaricide, and discloses a substituted benzanilide compound represented by the formula (1):...
US20130072494 INHIBITORS OF JUN N-TERMINAL KINASE  
The present disclosure provides inhibitors of c-Jun N-terminal kinases (JNK) having a structure according to the following formula: or a salt or solvate thereof, wherein ring A, Ca, Cb, Z, R5, W...
US20100331335 Inhibitors of Jun N-Terminal Kinase  
The present disclosure provides inhibitors of c-Jun N-terminal kinases (JNK) having a structure according to the following formula: or a salt or solvate thereof, wherein ring A, Ca, Cb, Z, R5, W...
US20110105460 TRIAZOLE DERIVATIVE OR SALT THEREOF  
[Problem] A compound, which can be used for preventing or treating diseases, in which 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) is concerned, in particular, diabetes, insulin resistance,...
US20090048156 HDAC INHIBITORS AND HORMONE TARGETED DRUGS FOR THE TREATMENT OF CANCER  
The present invention relates to the methods of treating endocrine-regulated cancers, including hormone resistant cancers, for example. More specifically, the present invention relates to a method...
US20060252766 Methods using a combination of 3-heteroaryl-2-indolinone and a cyclooxygenase-2 inhibitor for the treatment of neoplasia  
The present invention provides methods and compositions useful for treatment or prevention of neoplasia by administering a combination comprising a 3-heteroaryl-2-indolinone compound and a COX-2...
US20140342912 AROMATIC PHOSPHATE ESTERS AS AGROCHEMICAL FORMULATION COMPONENT  
This invention relates to the use of aromatic phosphate esters of formula (I) wherein R1, R2 and R2 are as defined within the description, as adjuvants in compositions, particularly for...
US20080045484 Use of Aromatase Inhibitors for Endometrial Thinning in Preparation for Surgical Procedures on the Endometrial Cavity and Uterus  
Aromatase inhibitors are administered to a female patient prior to endometrial ablation or resection procedures in order to thin the endometrium to a thickness of less than 6 mm, and preferably...
US20150164076 SYNERGISTIC COMPOSITIONS FOR THE PROTECTION OF AGRARIAN CROPS AND THE USE THEREOF  
Synergistic compositions comprising: one component (A), consisting of the compound having formula (I) 3-difluoromethyl-N-(7-fluoro-1,1,3-trimethyl-4-indanyl)-1-me thyl-4-pyrazolecarboxamide one or...
US20140100107 TERNARY FUNGICIDAL COMPOSITIONS COMPRISING A DITHIINO-TETRACARBOXAMIDE FUNGICIDE  
The present invention relates to active compound combinations, in particular within a fungicide composition, which comprises (A) a dithiino-tetracarboximide of formula (I), (B) an inhibitor of the...
US20130129839 FUNGICIDAL PYRAZOLES AND THEIR MIXTURES  
Disclosed is a fungicidal composition comprising (a) at least one compound selected from the compounds of Formula 1, N-oxides, and salts thereof, wherein R1, R2, R3, R4, R5 and R6 are as defined...
US20150173349 Agroformulation comprising copolymer of an amide, polyalkylene glycol (meth)acrylate, and alkyl (meth)acrylate  
The present invention provides a composition comprising a pesticide and a copolymer, which contains in polymerized form an amide (monomer A) containing at least one of N-vinyllactame, N—C1-C6...
US20110059959 NOVEL MULTICYCLIC COMPOUNDS AND THE USE THEREOF  
The present invention is directed to novel multicyclic molecules that mediate enzymatic activity. In particular, the compounds may be effective in the treatment of diseases or disease states...
US20080039481 Seed Dressing for Soya Bean  
The use of one or more DMI fungicides from the group consisting of: a) triazoles: a.1. azaconazole, a.2. bitertanol, a.3. bromuconazole, a.4. cyproconazole, a.5. difenoconazole, a.6. diniconazole,...
US20140221421 THERAPEUTIC COMPOUNDS  
Compounds of formula I: or salts thereof are disclosed. Also disclosed are pharmaceutical compositions comprising a compound of formula I, processes for preparing compounds of formula I,...
US20090270440 BIOAVAILABILITY OF ACTIVE SUBSTANCES HAVING AN AMIDINE FUNCTION IN MEDICAMENTS  
The invention relates to the use of N,N′-dihydroxyamidine (I), N,N′-dihydroxyamidine ether (II), N,N′-dihydroxyamidine diether (III), N,N′-dihydroxyamidine ester (IV), N,N′-dihydroxyamidine...
US20110144171 THIOPENE CONTAINING ANALOGUES OF FLUCONAZOLE AS ANTIFUNGAL AGENTS AND PROCESS FOR THEIR PREPARATION  
The present invention discloses novel compounds of the Formula (1), containing thiophene moieties and pharmaceutically acceptable salts thereof, methods for preparing these compounds, the use of...
US20110294861 METHOD OF TREATMENT OF HEREDITARY HEMOCHROMATOSIS  
The present invention relates to the use of Compound I of the following formula in the treatment of iron overload resulting from hereditary hemochromatosis in patient in need of such a treatment...
US20110105575 METHOD OF TREATMENT OF HEREDITARY HEMOCHROMATOSIS  
The present invention relates to the use of Compound I of the following formula in the treatment of iron overload resulting from hereditary hemochromatosis in patient in need of such a treatment...
US20080193499 Angiogenesis Inhibitors  
Described herein are methods of inhibiting angiogenesis, and treating or preventing a disease or disorder (or symptoms thereof) associated with angiogenesis, wherein an anti-angiogenesis compound...
US20080287512 Plant Protection Composition Including an Active Compound Selected from Azoles and a Solvent, and Useful Solvent Composition  
The present invention relates to a concentrated plant protection composition containing an active compound selected from azoles and preferable triazoles such as tebuconazole. The composition...